NT5C2 rs1168312: Understanding This Genetic Variant
The rs1168312 variant is a single nucleotide polymorphism located within the NT5C2 gene. It has been studied in the context of clinical oncology, particularly regarding its potential impact on cellular function and patient cohorts in Singapore.
What each genotype means
Typical NT5C2 variant profile
This genotype represents the most common form of the rs1168312 variant observed in many populations. Research into this specific marker in Singaporean cohorts has explored its potential role in protein function, though current evidence regarding its clinical impact remains limited. You should not use this information to make health decisions, as the functional consequences of this variant are not fully established.
This is the major allele genotype and is found in the majority of individuals across most global populations.
Heterozygous NT5C2 variant profile
You carry one copy of each allele for this genetic marker. Studies investigating this variant in clinical oncology cohorts have sought to understand its influence on protein function, but the evidence remains preliminary and inconclusive. Please consult with a healthcare professional if you have concerns about your health or specific clinical risks.
This heterozygous genotype is observed at varying frequencies depending on ancestral background, appearing in a significant minority of individuals in studied cohorts.
Minor allele NT5C2 profile
This genotype represents the less common variant at this position. While this SNP has been mapped in studies looking at protein function within oncology patient groups, the clinical significance of carrying this specific genotype is not currently well-defined. This information is for educational purposes and does not constitute a medical diagnosis or risk assessment.
This genotype is the least common of the three and is found at lower frequencies in most populations studied to date.
What is rs1168312?
The rs1168312 variant is a specific change in the DNA sequence, known as a single nucleotide polymorphism (SNP), located within the NT5C2 gene. SNPs are the most common type of genetic variation among people, representing a difference in a single building block of DNA. This particular variant is cataloged in international databases that track genetic diversity and its potential links to human health. While many SNPs have no observable effect on health, researchers study them to determine if they influence how our bodies function or respond to environmental factors. In the case of rs1168312, its location within the NT5C2 gene has drawn interest from scientists investigating the molecular mechanisms of certain diseases, particularly in oncology research where understanding genetic drivers of cellular behavior is a primary focus.
The Role of the NT5C2 Gene
The NT5C2 gene provides instructions for making an enzyme called cytosolic 5'-nucleotidase II. This enzyme plays a critical role in regulating the levels of nucleotides, which are the essential building blocks of DNA and RNA. By controlling the breakdown of these molecules, the NT5C2 enzyme helps maintain the delicate balance required for normal cellular metabolism. Research has shown that the NT5C2 gene is highly significant in the context of acute lymphoblastic leukemia (ALL). Specifically, certain activating mutations in this gene have been identified as drivers of resistance to chemotherapy drugs like 6-mercaptopurine. Because of this, the gene is a subject of intense study to understand how its activity levels—whether normal or altered—might influence how cells grow, divide, and respond to therapeutic interventions in clinical settings.
Research Associations and Evidence Strength
The evidence linking rs1168312 to specific clinical outcomes is currently classified as limited. Most research involving the NT5C2 gene focuses on its role in drug resistance during cancer treatment, but rs1168312 itself is primarily mapped as a variant of interest in specific patient cohorts, such as those studied in Singapore. It is important to distinguish between the well-documented activating mutations that drive drug resistance in leukemia and this specific SNP, which does not necessarily share the same functional impact. Because the evidence is limited and often derived from specific, localized populations, it is not yet clear how this variant influences health outcomes in the general, diverse global population. Scientists continue to investigate whether such variants contribute to broader metabolic differences or if they are simply markers of ancestral genetic background.
Population Frequency and Interpretation
Genetic variants like rs1168312 are not distributed equally across the globe. Population frequency refers to how often a specific allele appears in a given group of people. For rs1168312, data is largely derived from studies involving Singaporean cohorts, which provides a snapshot of its prevalence in that specific demographic. Because genetic architecture varies significantly between ancestries, the frequency observed in one group may not reflect the frequency in another. When interpreting this information, it is essential to remember that having a particular genotype does not equate to a diagnosis or a guaranteed health outcome. Genetic data is complex, and most traits are influenced by a combination of many genes, environmental factors, and lifestyle choices. This information is intended for educational purposes and should not be used to make personal health decisions.
What You Can Do With This Information
Understanding your genetic profile can be an interesting way to learn about your biological makeup, but it is important to approach this information with caution. You cannot use the presence of the rs1168312 variant to diagnose yourself with any condition or to predict a specific response to medication. If you have concerns about your health, your family history, or how your body might respond to a particular treatment, the most important step is to consult with a qualified healthcare professional. A doctor or a genetic counselor can help you interpret genetic information in the context of your overall health and medical history. Never make changes to your prescribed medications or treatment plans based on information found online. Always discuss any questions regarding your genetic data with your clinician or pharmacist, who can provide guidance based on established clinical standards.
How common is this variant?
The frequency of rs1168312 varies by ancestry, with specific data points often derived from Singaporean cohorts as noted in regional genetic research.
Frequently asked questions
Is rs1168312 a cause of cancer?
No, rs1168312 is a genetic variant and not a direct cause of cancer. While the NT5C2 gene is involved in cancer research, this specific SNP is not classified as a causative mutation for developing the disease.
Should I be worried if I have the G allele?
There is no reason for concern based on this variant alone. Genetic variants are common, and most do not have a significant impact on your health or daily life.
Can this SNP predict my response to chemotherapy?
While the NT5C2 gene is studied for its role in drug resistance, rs1168312 is not currently used as a clinical marker for predicting chemotherapy response. Always consult your oncologist regarding your specific treatment plan.
Where can I find more information about my own genetics?
If you are interested in your genetic profile, you can speak with a healthcare provider or a certified genetic counselor. They can help you understand the limitations and potential insights of genetic testing.
Sources & further reading
Educational information only, last refreshed 9/25/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1168312?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29